Decibel Cannabis CoTSXV:DB 44 EBITDA Margin % is 1.25% as of Mar. 2026, which is 59% below its 10-year median of 3.06. GuruFocus rates TSXV:DB with a GF Score™ of 44/100 and a GF Value™ of C$0.11 (Fairly Valued). The stock has 6 warning signs investors should review. Among 955 Drug Manufacturers companies, Decibel Cannabis Co ranks worse than 67.43% on this metric.
Decibel Cannabis Co (TSXV:DB) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Decibel Cannabis Co EBITDA Margin % Related Terms
Decibel Cannabis Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Decibel Cannabis Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Decibel Cannabis Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Decibel Cannabis Co EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Decibel Cannabis Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Decibel Cannabis Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Decibel Cannabis Co (TSXV:DB) has a EBITDA Margin % of 1.25% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Decibel Cannabis Co and its competitors. This is 59% below median its historical median of 3.06. According to the industry distribution chart, Decibel Cannabis Co ranks #644 out of 955 companies in the Drug Manufacturers industry, placing it in the top 67.4%.
Is Decibel Cannabis Co's EBITDA Margin % too high?
Decibel Cannabis Co's current EBITDA Margin % of 1.25% is 59% below median its 10-year median of 3.06. The Drug Manufacturers industry median EBITDA Margin % is 12.39. Decibel Cannabis Co's value of 1.25% is 89.9% below this industry median. Based on the distribution chart, Decibel Cannabis Co ranks #644 out of 955 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Decibel Cannabis Co has a GF Score™ of 44/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Decibel Cannabis Co's EBITDA Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Decibel Cannabis Co ranks #644 out of 955 companies for EBITDA Margin %. This places Decibel Cannabis Co in the lower half of its industry. The industry median EBITDA Margin % is 12.39. Decibel Cannabis Co's value of 1.25% is 89.9% below this benchmark. While the company's 10-year median is 3.06 vs. the industry median of 12.39, Decibel Cannabis Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.39, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Decibel Cannabis Co's current EBITDA Margin % of 1.25% is 89.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Decibel Cannabis Co and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Decibel Cannabis Co's current EBITDA Margin % is 1.25%, which is 59% below median its own 10-year median of 3.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Decibel Cannabis Co stock overvalued right now?
Based on GuruFocus' analysis, Decibel Cannabis Co (TSXV:DB) is currently considered Fairly Valued. The stock's GF Value™ is C$0.11, compared to a current price of C$0.12 — trading 9.1% above its estimated fair value. The current EBITDA Margin % is 1.25%, which is 59% below median its 10-year median of 3.06 and 89.9% below the Drug Manufacturers industry median of 12.39. Decibel Cannabis Co's overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Decibel Cannabis Co (TSXV:DB), the current EBITDA Margin % is 1.25% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Decibel Cannabis Co (TSXV:DB) Overvalued in 2026?
Based on GuruFocus' analysis, Decibel Cannabis Co stock appears to be overvalued.
The current stock price of C$0.12 is trading 9.1% above its estimated GF Value™ of C$0.11.
GuruFocus considers Decibel Cannabis Co to be Fairly Valued.
Key valuation signals for TSXV:DB:
EBITDA Margin %: 1.25% (59% below median its 10-year median of 3.06)
GF Value™: C$0.11 vs. price of C$0.12 (9.1% above fair value)
Industry Position: 89.9% below the Drug Manufacturers median (#644 of 955)
No single metric tells the full story. See the TSXV:DB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Decibel Cannabis Co Inc is engaged in the cannabis operations business. The company is involved in the production, distribution, and sale of recreational cannabis. All the revenues are generated in Canada. The company's revenue is comprised of wholesale sales of both products and services through its production facilities to distributors and licensed cannabis producers and the direct sale of products through its retailer locations to end customers.
44GF Score
Get the complete analysis for TSXV:DB
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:DB has been successfully added to your 
